F11R and breast cancer: However, JAM-A expression had no statistical association with HER2 expression or age in the tissue from the TMA we tested, reflecting the very small number of patients who had HER2-positive tumors or were younger than 50 years old; further evidencing the inequal distribution amongst breast cancer subtypes and the late incidence within the population tested.